It is believed that the use of a homogeneous population, however small, can ensure the data uniformity necessary to identify a predictive model that, once refined, can be integrated into clinical practice to personalize the diagnostic pathway and, potentially, the surgical approach.
Abstract
Simple Summary This radiomic study evaluated whether radiomic features from preoperative 2-[18F]FDG PET/CT scans can predict occult lymph node metastases in early-stage non-small cell lung cancer (NSCLC). We enrolled patients with cT1N0 NSCLC with or without occult unexpected node metastasis after surgical resection. Radiomic features of the first and second level were evaluated and machine learning protocol was used to elaborate a predictive model. Both PET/CT and clinical protocols were identical for all patients and were performed at the same institution, providing robust, uniform data with consistent reconstruction parameters, thereby minimizing the data harmonization issue. Despite the inherent limitations of radiomics studies, we believe that the use of a homogeneous population, however small, can ensure the data uniformity necessary to identify a predictive model that, once refined, can be integrated into clinical practice to personalize the diagnostic pathway and, potentially, the surgical approach as well.
The clinico-radiological variables analyzed using ML showed a predictive performance similar to that of a radiologist in this setting, and the radiomic and combined models achieved a moderate and heterogeneous performance.
Marta García Cerezo, David López Cornejo, Alba Ortigosa-Palomo et al.· Applied Sciences· 0 citations
Background Non-small cell lung cancer (NSCLC) staging relies on accurate assessment of mediastinal lymph nodes. This study investigates the utility of radiomic features derived from contrast-enhanced thoracic CT scans in predicting malignancy in clinically positive (cN+) mediastinal lymph nodes. Methods A retrospective...
Judith Legrand, Antoine Decoux, L. Duron et al.· PLoS ONE· 0 citations
By identifying low-risk patients within the NCCN high-risk group and high-risk patients within the NCCN low + intermediate-risk group for recurrence, these models may support treatment de-escalation and escalation, respectively, pending prospective multicenter validation.
N. Chakrabarty, S. Rane, U. Sherkhane et al.· Frontiers in Oncology· 1 citation
A model integrating radiomics and clinical data may serve as a potentially effective tool for preoperative risk stratification of mediastinal tumors; this model shows great promise for optimizing individualized surgical planning.
Kun Li, Xiang-Yu Xie, Yi-Fei Feng et al.· Frontiers in Surgery· 0 citations
Esophageal Cancer: Other
Medical Artificial Intelligence (MAI) is expanding within surgical oncology with new tools emerging for assisting cancer multidisciplinary teams (MDTs) in cancer types such as oesophageal cancer (OC). Radiomics has similarly gained popularity with proponents arguing that it provide...
Jakub J. Dylag, D. Burns, N. Thavanesan et al.· Diseases of the esophagus· 0 citations
In locally advanced gastric cancer, a substantial number of patients relapse with liver metastasis months after an apparently curative operation, and standard tumor staging offers little warning of who is at risk. Here, we develop the Radiopathomics-Clinical Stratification Assessment (RCSA), an interpretable model that...